BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34589418)

  • 1. Addition of Induction or Consolidation Chemotherapy in Definitive Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy Alone for Patients With Unresectable Esophageal Cancer: A Systematic Review and Meta-Analysis.
    Wang J; Xiao L; Wang S; Pang Q; Wang J
    Front Oncol; 2021; 11():665231. PubMed ID: 34589418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Survival in Nonsurgical Esophageal Cancer Patients Who Received Consolidation Chemotherapy Compared With Patients Who Received Concurrent Chemoradiotherapy Alone: A Systematic Review and Meta-Analysis.
    Xia X; Liu Z; Qin Q; Di X; Zhang Z; Sun X; Ge X
    Front Oncol; 2020; 10():604657. PubMed ID: 33489910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction immunotherapy plus chemotherapy followed by definitive chemoradiation therapy in locally advanced esophageal squamous cell carcinoma: a propensity-score matched study.
    Lian HM; Wu JL; Liufu WJ; Yu TT; Niu SQ; Bao Y; Peng F
    Cancer Immunol Immunother; 2024 Feb; 73(3):55. PubMed ID: 38366287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of docetaxel, cisplatin and fluorouracil (TPF)-based induction chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis.
    Zhou R; Zhu J; Chen X; Liu Y; Wang Y; Zhang T
    Clin Transl Oncol; 2020 Mar; 22(3):429-439. PubMed ID: 31165410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and safety of induction chemotherapy combined with concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients: a systematic review and meta-analysis.
    Wang BC; Xiao BY; Lin GH; Wang C; Liu Q
    BMC Cancer; 2020 May; 20(1):393. PubMed ID: 32375701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of consolidation chemotherapy after concurrent chemoradiation on the prognosis of locally advanced cervical cancer: a systematic review and meta-analysis.
    Zhong L; Li K; Song L; Yin R
    J Obstet Gynaecol; 2022 Jul; 42(5):830-837. PubMed ID: 35148230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety of concurrent chemoradiotherapy with induction chemotherapy
    Liu Y; Yang L; Zhang S; Lin B
    Transl Cancer Res; 2022 May; 11(5):1207-1218. PubMed ID: 35706809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment Plasma EBV-DNA Load Guides Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Cancer: A Meta-Analysis.
    Lai L; Chen X; Zhang C; Chen X; Chen L; Tian G; Zhu X
    Front Oncol; 2020; 10():610787. PubMed ID: 33665166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of induction and adjuvant chemotherapy in combination with concurrent chemoradiotherapy for nasopharyngeal cancer: a Bayesian network meta-analysis of published randomized controlled trials.
    Yu H; Gu D; He X; Gao X; Bian X
    Onco Targets Ther; 2016; 9():159-70. PubMed ID: 26793000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial.
    Yang Q; Cao SM; Guo L; Hua YJ; Huang PY; Zhang XL; Lin M; You R; Zou X; Liu YP; Xie YL; Wang ZQ; Mai HQ; Chen QY; Tang LQ; Mo HY; Cao KJ; Qian CN; Zhao C; Xiang YQ; Zhang XP; Lin ZX; Li WX; Liu Q; Li JB; Ling L; Guo X; Hong MH; Chen MY
    Eur J Cancer; 2019 Sep; 119():87-96. PubMed ID: 31425966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of induction chemotherapy in patients with locally advanced nonsmall cell lung cancer who received chemoradiotherapy: A systematic review and meta-analysis.
    Luo H; Yu X; Liang N; Xie J; Deng G; Liu Q; Zhang J; Zhang J; Ge H
    Medicine (Baltimore); 2017 Feb; 96(8):e6165. PubMed ID: 28225501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which treatment is better than concurrent chemoradiotherapy about survival for stage III or IV locally advanced nasopharyngeal carcinoma? An updated Bayesian network meta-analysis of randomized controlled trials.
    Fang L; Shi L; Wang W; Hu T; Rao X
    Eur Arch Otorhinolaryngol; 2021 Oct; 278(10):3633-3642. PubMed ID: 33598731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction chemotherapy with concurrent chemoradiotherapy versus concurrent chemoradiotherapy for locally advanced squamous cell carcinoma of head and neck: a meta-analysis.
    Zhang L; Jiang N; Shi Y; Li S; Wang P; Zhao Y
    Sci Rep; 2015 Jun; 5():10798. PubMed ID: 26041604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consolidation Chemotherapy Rather than Induction Chemotherapy Can Prolong the Survival Rate of Inoperable Esophageal Cancer Patients Who Received Concurrent Chemoradiotherapy.
    Xia X; Wu M; Gao Q; Sun X; Ge X
    Curr Oncol; 2022 Sep; 29(9):6342-6349. PubMed ID: 36135068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival Comparision of Three-dimensional Radiotherapy Alone vs. Chemoradiotherapy for Esophageal Squamous Cell Carcinoma.
    Zhang AD; Su XH; Shi GF; Han C; Wang L; Liu H; Zhang J; Zhang RH
    Arch Med Res; 2020 Jul; 51(5):419-428. PubMed ID: 32418649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Effect of Radiotherapy Combined with Chemotherapy for Non-Surgical Treatment of the Esophageal Squamous Cell Carcinoma.
    Chen H; Zhou L; Yang Y; Yang L; Chen L
    Med Sci Monit; 2018 Jun; 24():4183-4191. PubMed ID: 29915168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction chemotherapy for locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiation: A systematic review and meta-analysis.
    Tan TH; Soon YY; Cheo T; Ho F; Wong LC; Tey J; Tham IWK
    Radiother Oncol; 2018 Oct; 129(1):10-17. PubMed ID: 29555182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Concurrent Chemoradiotherapy Combined With Induction Chemotherapy or Adjuvant Chemotherapy in Patients With Stage II-IVA Nasopharyngeal Carcinoma: A Propensity Score Matching Analysis and Meta-Analysis.
    Yang J; Liang ZG; Jiang YT; Chen KH; Li L; Qu S; Zhu XD
    Front Oncol; 2021; 11():778836. PubMed ID: 34926289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction chemotherapy plus IMRT alone versus induction chemotherapy plus IMRT-based concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.
    Wei Z; Zhang Z; Luo J; Li N; Peng X
    J Cancer Res Clin Oncol; 2019 Jul; 145(7):1857-1864. PubMed ID: 31062162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of induction chemotherapy plus concurrent chemoradiotherapy and induction chemotherapy plus radiotherapy in locally advanced nasopharyngeal carcinoma.
    Wang Q; Xu G; Xia Y; Zuo J; Zeng G; Xue Z; Cao R; Xiong W; Li W
    Oral Oncol; 2020 Dec; 111():104925. PubMed ID: 32721816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.